参考文献/References:
[1] ZHANG Haohua, ZHANG Nianli, JIANG Wenbin, et al. Clinical significance of the long non-coding RNA NEAT1/miR-129-5p axis in the diagnosis and prognosis for patients with chronic heart failure[J]. Experimental and Therapeutic Medicine, 2021, 21(5): 512.
[2] LING Shuang, XU Jinwen. NETosis as a pathogenic factor for heart failure[J]. Oxidative Medicine and Cellular Longevity, 2021, 2021: 6687096.
[3] YANG Zecheng, CHEN Shuaitong, YING Haoqiang, et al. Targeting syndecan-1: new opportunities in cancer therapy[J]. American Journal of Physiology·Cell Physiology, 2022, 323(1): C29-C45.
[4] MALLICK R, YL?-HERTTUALA S. Therapeutic potential of VEGF-B in coronary heart disease and heart failure: dream or vision[J]. Cells, 2022, 11(24): 4134.
[5] KIVEL? R, HEMANTHAKUMAR K A, VAPARANTA K, et al. Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling[J]. Circulation, 2019, 139(22): 2570-2584.
[6] 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志, 2018, 2(4):196-225. Heart Failure Group of Chinses Society of Cardiology of Chinses Medical Association, Chinses Heart Failure Association of Chinses Medical Doctor Association, Editorial Board of Chinses Journar of Cardioloy. Chinese guidelines for the diagnosis and trentment of heart failure 2018 [J]. Chinese Journal of Heart Failure and Cardiomyopathy, 2018, 2(4): 196-225.
[7] 胡小燕, 郑晓, 嵇华夏, 等.血清PCT 与BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J]. 现代检验医学杂志, 2021,36(3):128-131, 136. HU Xiaoyan, ZHENG Xiao, JI Huaxia, et al. Clinical diagnostic value of combined detection of serum PCT and BNP levels in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with heart failure[J]. Journal of Modern Laboratory Medicine, 2021, 36(3): 128-131, 136.
[8] ALBAENI A, CHATILA K F, THAKKER R A, et al. In-Hospital outcomes of chronic total occlusion percutaneous coronary interventions in heart failure patients[J]. Current Problems in Cardiology, 2023, 48(2): 101458.
[9] OSUNDOLIRE S, GOLDBERG R J, LAPANE K L. Descriptive epidemiology of chronic obstructive pulmonary disease in US nursing home residents with heart failure[J]. Current Problems in Cardiology, 2023, 48(2): 101484.
[10] GROENEWEGEN A, RUTTEN F H, MOSTERD A, et al. Epidemiology of heart failure[J]. European Journal of Heart Failure, 2020, 22(8): 1342-1356.
[11] HAO Guang, WANG Xin, CHEN Zuo, et al. Prevalence of heart failure and left ventricular dysfunction in China:the China Hypertension Survey, 2012–2015[J]. European Journal of Heart Failure, 2019, 21(11): 1329-1337.
[12] SARMA S, STOLLER D, HENDRIX J, et al. Mechanisms of chronotropic incompetence in heart failure with preserved ejection fraction[J]. Circulation-Heart Failure, 2020, 13(3): e006331.
[13] ZUCHI C, TRITTO I, CARLUCCIO E, et al. Role of endothelial dysfunction in heart failure[J]. Heart Failure Reviews, 2020, 25(1): 21-30.
[14] WERNLY B, FUERNAU G, MASYUK M, et al. Syndecan-1 predicts outcome in patients with STsegment elevation infarction independent from infarctrelated myocardial injury[J]. Scientific Reports, 2019, 9(1): 18367.
[15] CHEN Youquan, HUANG Ming, YAN Yi, et al. Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis[J]. Bioengineered, 2021, 12(1): 8447-8456.
[16] SHARMA P, KAPOOR D, SHUKLA D. Role of heparanase and syndecan-1 in HSV-1 release from infected cells[J]. Viruses, 2022, 14(10): 2156.
[17] RANJBARAN A, NEJABATI H R, GHASEMNEJAD T, et al. Follicular fluid levels of adrenomedullin 2, vascular endothelial growth factor and its soluble receptors are associated with ovarian response during ART cycles[J]. Geburtshilfe Frauenheilkd, 2019, 79(1): 86-93.
[18] WIECZ?R R, RO?? D, WIECZ?R A M, et al. VASCULAR-1 and VASCULAR-2 as a new potential angiogenesis and endothelial dysfunction markers in peripheral arterial disease [J]. Clin Appl Thromb Hemost, 2019, 25:1076029619877440.
[19] HU Guanying, YANG Peng, ZENG Yu, et al. Danggui buxue decoction promotes angiogenesis by upregulation of VEGFR1/2 expressions and downregulation of sVEGFR1/2 expression in myocardial infarction rat[J]. Journal of the Chinese Medical Association , 2018, 81(1): 37-46.
[20] 崔泽岩, 孙倩, 周红霞. 血清糖类抗原125 和N 末端B 型脑钠肽前体对射血分数保留的心力衰竭的诊断与疗效判定及预后的评估价值[J]. 中国医药,2021, 16(4): 503-507. CUI Zeyan, SUN Qian, ZHOU Hongxia. Evaluation of serum carbohydrate antigen 125 and N-terminal probrain natriuretic peptide in diagnosis, efficacy judgment and prognosis of heart failure with preserved ejection fraction [J]. China Medicine, 2021, 16(4): 503-507.